Baptist Health System General Surgery Residency Program

Slides:



Advertisements
Similar presentations
Breast Cancer Patient Issues in Family Practice: An Interactive Session.
Advertisements

1 Physicians Involved in the Care of Patients with Recently Diagnosed Cancer CanCORS Provider Composition Writing Group Academy Health Annual Research.
Exhibit 1 NOTES: Other setting of usual care includes: neighborhood or family health center, free standing surgery center, rural health clinic, company.
LUNG CANCER LUNG CANCER Lung Cancer  What Is Lung Cancer?  Lung Cancer is a disease caused by the rapid growth and division of cells that make up the.
Mammary ductal carcinoma
Evidence for adjuvant radiation therapy benefiting breast cancer patients with 1 to 3 positive lymph nodes treated with a modified radical mastectomy and.
Subtraction: Adding UP
Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.
Fourth Quarter Oklahoma Data (October-December 2011)
516 (32723) Phase III trial comparing AC (x4)taxane (x4) with taxane (x8) as adjuvant therapy for node-positive breast cancer: Results of N-SAS-BC02.
BREAST CANCER IN IDAHO This PowerPoint presentation was created as a collaborative effort among the Cancer Data Registry of Idaho/ Idaho.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Kevin S. Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Associate Professor of Surgery Harvard.
Giuliano Pre-SSO mins ASCO Z mins
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Cancer Staging. What is cancer staging? Staging describes the severity of a person’s cancer based on the extent of the original (primary) tumor and whether.
SHELBY ADDISON NEAL, MD MENTORS: WILLIAM T. CREASMAN, MD WHITNEY S. GRAYBILL, MD, MS Lymph-Vascular Space Invasion (LVSI) in Uterine Corpus Cancer What.
Quality of Care and In-Hospital Outcomes in Patients With Coronary Heart Disease in Rural and Urban Hospitals (from Get With the Guidelines– Coronary.
Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.
Ductal Carcinoma in situ
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
INTRAOPERATIVE RADIATION THERAPY FOR EARLY STAGE BREAST CANCER Miranda Pernaski.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,
Factors Associated with Bilateral vs. Unilateral Mastectomy in a Diverse, Population-based Sample of Breast Cancer Patients Sarah T. Hawley, PhD, MPH University.
Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD.
Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.
Health Insider: More breast cancer patients should keep their healthy breasts, study says Karen Kaplan Los Angeles Times September 7, 2014
Cancer Staging.
The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-Regional Treatment Simona.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.
CBACT: Cost Benefit Analysis for Cancer Treatments Adeeti Aggarwal Saratoga High School February 20, 2009.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.
A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.
Evidence Based For invasive breast cancer BCT is Tumor excision, axillary node dissection, whole breast radiation Modified mastectomy is total mastectomy.
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2014 – December 31, 2014 Compiled by L.Day, RN BSN CCM CCRP OCN 1.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2009 – December 31, 2009.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2011 – December 31, 2011 Compiled by Lynn Day, RN BSN CCM CCRP.
2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2012 – December 31, 2012 Compiled by Uzma Nazim, M.D.
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2010 – December 31, 2010 Compiled by Lynn Day, RN BSN CCM CCRP.
Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently? Audrey Choi MD, Matthew Surrusco MD, Samuel Rodriguez MD, Khaled.
BREAST BRACHYTHERAPY OUTCOMES EVALUATION Margaret Pierce DNP, APRN, BC University of Tennessee Knoxville, Tennessee.
Presented at the NAACCR Annual Conference Quebec City June 22, 2010.
ABSTRACT Purpose This retrospective review was conducted to determine if delay in the start of radiotherapy after conservative breast surgery had any detrimental.
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Harvard Medical School Date 06/01/2007.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
Ari Brooks, MD Cancer Surgeon, Big Data End User
Prognostic significance of tumor subtypes in male breast cancer:
Ductal Carcinoma (Breast Cancer)
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Changing Surgical Trends in Young Patients with Early Stage Breast Cancer, 2003 to 2010: A Report from the National Cancer Data Base  Catherine E. Pesce,
Conventional Breast Image
Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM
Presentation transcript:

Baptist Health System General Surgery Residency Program Reasons for Mastectomy in Early Stage Breast Cancer: An Institutional Review Rosebella Agola, MD, MPH Greg Bearden MD, FACS Baptist Health System General Surgery Residency Program

Introduction Early stage breast cancer: cancer that has not spread beyond the breast or axillary lymph nodes Stage 0, I and II based on American Joint Commission on Cancer (AJCC) classification Surgical options for treating early stage breast cancer include Mastectomy: removing entire breast Breast conserving surgery (BCS): removing part of the breast or lumpectomy, followed by radiation therapy. Using breast conserving surgery (BCS) to treat patients with early stage breast cancer is a nationally accepted standard of care. A 50% breast conservation rate is considered the minimum standard in order to meet National Accreditation Program for Breast Centers (NAPBC) compliance Compliance is evaluated annually. Published data shows that most centers exceed the 50% BCS rate. At Princeton Hospital the overall rate of BCS over two years (2010 to 2011) was 54%.

Princeton Hospital BCS Rates Comparing 2010 and 2011 BCS rate fell from 61% to 50%

Objective To find out reasons why patients with stage 0-II breast cancer were treated with mastectomy over breast conserving surgery.

Materials and Methods A retrospective review of data from Princeton Hospital’s Breast Cancer registry was conducted to identify patients with Stage 0, I and II breast cancer who were treated with either mastectomy or BCS between 2010 and 2011 Exclusion criteria included surgery done at an outside facility or incomplete data in the medical chart. Reasons for mastectomy were identified as: Patient choice Surgeon choice Failed BCS (inability to obtain negative margins after lumpectomy) Bilateral breast cancer Previous breast cancer Multicentricity

Material and Methods The medical chart of each patient in the mastectomy group was reviewed to identify reasons for mastectomy. The following data were also reviewed regarding patient and tumor characteristics in each group Race Age Histology Tumor stage Tumor Size Node status Patient and tumor characteristics were then independently compared between the BCS group and the mastectomy group. Odds ratios (ORs) were analyzed to determine association with mastectomy. This was done using MS Excel XLSTAT software.

Results Between January 2010 and December 2011, 218 patients had surgery for early stage breast cancer. 28 patients were excluded based on our exclusion criteria. A total of 190 patients were identified as either having had a mastectomy or BCS at Princeton Hospital 89 patients in the mastectomy group 101 patients in the BCS group. Patient and tumor characteristics were reviewed and compared according to surgery type.

Results Results of medical chart review of mastectomy group 79% (70 out of 89) of patients in the mastectomy group had identifiable reasons for mastectomy. Patient choice (31% ) Surgeon choice( 3% ) Failed BCS(28%) Previous breast cancer (15%) Bilateral breast cancer (9%) Multicentricity (8%)

Mastectomy Group

Results 21% (19 out of 89) patients in the mastectomy group had unknown reasons for mastectomy. Characteristics of this group Mean age of 63. All had invasive cancer. 63% (12 out of 19) had tumor stage II. 68% (13 out of 19) had tumor size < 3cm. 68% (13 out of 19) had negative node status.

Results Patient and tumor characteristics were analyzed to determine if they were positively associated with mastectomy. Neither race nor age showed a statistically significant association with increased likelihood of mastectomy (P>0.05, respectively). Invasive cancer (OR 3.4), positive node status (OR 2.5) tumor stage II (2.23) and tumor size >3cm (OR 3.17) were all independently associated with an increased likelihood of mastectomy over BCS (p<0.05, respectively).

Conclusion Patient choice was the most common reason for mastectomy . These patients were candidates for BCS on initial evaluation Patients likely opted out based on personal perceptions of increased risk, family history or for “peace of mind.” Published studies have also shown patient choice to be a significant determinant of mastectomy rates. Patients with bilateral breast cancer, history of previous breast cancer, and multicentricity contributed to the overall mastectomy rate but were not candidates for BCS on initial evaluation. Failed BCS included patients who initially opted for BCS Surgeon choice/influence has been reported as a significant predictor of BCS versus mastectomy rates in other studies

Conclusion Shortcomings of study based on chart documentation Unless explicitly stated in the chart it was difficult to determine precise reasons for opting for mastectomy. We suggest a prospective analysis where specific reasons for choosing mastectomy versus BCS are documented in the breast cancer registry. Can be used to accurately track and analyze specific determinants of breast conservation versus mastectomy rates. This information can also be used to improve compliance with NAPBC standards. Future directions Further analysis of patient and tumor characteristics to determine true predictors of BCS versus mastectomy Analysis of surgeon characteristics and association with BCT versus mastectomy

Acknowledgements Dr Greg Bearden, MD, FACS Judy Lang, Cancer/Trauma Registry Coordinator, Princeton Baptist Medical Center

References Lee MC, Rogers K, Griffith K, et al “ Determinants of Breast Conservation Rates: Reasons for Mastectomy at a Comprehensive Cancer Center.” Breast J. 2009. Jan-Feb: 15(1):31-40. Hiotis, K., Ye W., Sposto R, and Sinner, KA” Predictors of breast conservation therapy. “Cancer. 2005, 103: 892-899. Kandace PM, Alredo AS, et al “ Are Mastectomies on the rise? A 13-Year Trend Analysis of the Selection of Mastectomy Versus Breast Conservation Therapy “ Ann Surg Oncol (2009) 16: 2682-2690. National Accreditation Program for Breast Centers , “ Breast conservation” NAPBC Standards Manual .2012:32. Morrow, M., White, J., et al” Factors Predicting the use of Breast Conserving Therapy in Stage I and II Breast Carcinoma” Am Soc Clin Oncol, 2001, 19: 2254-2260 Reitsamer R., et al “Predictors of Mastectomy in a Certified Breast Center”. Breast J.2008 Jul-Aug: 14 (4):2314-9. Adkisson CD., et al “Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer” Ann Surg Oncol. 2012 Apr; 19(4):1129-36.